Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE study

International Journal of Cardiology

Volumn 174, Issue 2, 2014, Pages 383-384

  Oyama, Jun Ichi ^a   Ishizu, Tomoko ^b   Sato, Yasunori ^c   Kodama, Kazuhisa ^a   Bando, Yasuko K ^d   Murohara, Toyoaki ^d   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Carotid artery intima media thickness; Sitagliptin

Indexed keywords

HEMOGLOBIN A1C; SITAGLIPTIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PYRAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; ARTERIAL WALL THICKNESS; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; ATHEROSCLEROSIS; CLINICAL TRIAL; COMPLICATION; DIABETIC ANGIOPATHIES; METHODOLOGY; MULTICENTER STUDY;

ADULT; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; PROSPECTIVE STUDIES; PYRAZINES; RESEARCH DESIGN; TRIAZOLES;

EID: 84901188346     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.204     Document Type: Article

References (9)

1. T.E. Craven, J.E. Ryu, and M.A. Espeland et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study Circulation 82 1990 1230 1242
2. Z. Khoury, R. Schwartz, S. Gottlieb, A. Chenzbraun, S. Stern, and A. Keren Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound Am J Cardiol 80 1997 1429 1433
3. L.E. Chambless, G. Heiss, and A.R. Folsom et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am J Epidemiol 146 1997 483 494
4. J.T. Salonen, and R. Salonen Ultrasound B-mode imaging in observational studies of atherosclerotic progression Circulation 87 1993 II56 II65
5. R. Kasami, H. Kaneto, and N. Katakami et al. Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease Diabetes Care 34 2011 468 470
6. M.A. Espeland, D.H. O'leary, J.G. Terry, T. Morgan, G. Evans, and H. Mudra Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors Curr Control Trials Cardiovasc Med 6 2005 3
7. J. Matsubara, S. Sugiyama, and K. Sugamura et al. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice J Am Coll Cardiol 59 2012 265 276
8. T. Nyström, M.K. Gutniak, and Q. Zhang et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease Am J Physiol Endocrinol Metab 287 2004 E1209 E1215
9. J.H. Stein, C.E. Korcarz, and R.T. Hurst Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the american society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine J Am Soc Echocardiogr 21 2008 93 111